The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Estrogen Receptor-β-selective Ligands Alleviate High-fat Diet- and Ovariectomy-induced Obesity in Mice
Open accessAbstract
Obesity is an epidemic problem affecting millions of people in the Western hemisphere and costs the United States economy more than $200 billion annually. Currently, there are no effective treatments to combat obesity. Recent studies have implicated the constitutive activity of estrogen receptor (ER) β as an important regulator of metabolic diseases. However, the potential of ER-β-selective ligands to offset obesity is not clear. We evaluated the pharmacological effect of ER-β-selective ligands (β-LGNDs) in animal models of high-fat diet- and ovariectomy-induced obesity. Ligand binding, transactivation, and uterotrophic studies with β-LGNDs demonstrated selectivity for ER-β over ER-α. Animals fed a high-fat diet showed a significant increase in body weight, and this weight gain was attenuated by β-LGNDs. High-fat diet-mediated increases in serum cholesterol, leptin, glucose, and fat accumulation in organs were also reduced by β-LGNDs. In addition, MRI scanning indicated that β-LGNDs altered body composition by reducing fat mass and increasing lean body mass. Organ weights and gene expression analyses demonstrated that adipose tissue is the center of action for β-LGNDs, and the reduction in body weight is likely due to increased energy expenditure. In vitro and in vivo mechanistic studies indicated that the anti-obesity effects of β-LGNDs were due to indirect peroxisome proliferator-activated receptor γ antagonistic actions requiring the ligand binding domain of ER-β and through abrogation of the ability of PGC-1 to coactivate peroxisome proliferator-activated receptor γ. In conclusion, these studies indicate that ligand-activated ER-β is a potential therapeutic target to combat obesity and obesity-related metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the absence of any reported changes in fat deposition in global ERβ KO mice, agonistic ERβ‐selective ligands have been reported to mitigate diet‐induced obesity in male mice.”
From The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments (2022) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G. J. M., Enmark, E., Pelto‐Huikko, M., Nilsson, S., & Gustafsson, J.-Α. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,802
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,879
PRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Genetics of gene expression and its effect on disease
Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., et al. (2008) · Nature · doi:10.1038/nature06758 · Cited by 1,296
Transcriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,039
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
Variations in DNA elucidate molecular networks that cause disease
Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S. K., et al. (2008) · Nature · doi:10.1038/nature06757 · Cited by 887
Fatty acid synthase, a proficient multifunctional enzyme
Wakil, S. J. (1989) · Biochemistry · doi:10.1021/bi00437a001 · Cited by 823
Liu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., et al. (2009) · Nature Medicine · doi:10.1038/nm.1994 · Cited by 796
Macrophage inflammatory protein-1
Maurer, M., & von Stebut, E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.019 · Cited by 769
Lipoprotein lipase: from gene to obesity
Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 741
Relationship of Obesity with Osteoporosis
Zhao, L.-J., Liu, Y., Liu, P.-Y., Hamilton, J., Recker, R. R., & Deng, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0572 · Cited by 626
Nguyen, D. M., & El-Serag, H. B. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.12.014 · Cited by 531
The Function of Leptin in Nutrition, Weight, and Physiology
Friedman, J. M. (2002) · Nutrition Reviews · doi:10.1301/002966402320634878 · Cited by 509
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity
Shi, Y., & Burn, P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1469 · Cited by 345
Analysis of an expression profile of genes in the human adipose tissue
Maeda, K., Okubo, K., Shimomura, I., Mizuno, K., Matsuzawa, Y., & Matsubara, K. (1997) · Gene · doi:10.1016/s0378-1119(96)00730-5 · Cited by 293
Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ
Foryst‐Ludwig, A., Clemenz, M., Hohmann, S., Hartge, M., Sprang, C., Frost, N., Krikov, M., Bhanot, S., Barros, R. P. A., Morani, A., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000108 · Cited by 291
Estrogen Receptor-β: Recent Lessons from in Vivo Studies
Harris, H. A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0459 · Cited by 284
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Mechanisms of obesity and related pathologies: The macro‐ and microcirculation of adipose tissue
Rutkowski, J. M., Davis, K. E., & Scherer, P. E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07303.x · Cited by 254
The psychiatric side-effects of rimonabant
Moreira, F. A., & Crippa, J. A. S. (2009) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462009000200012 · Cited by 245
How strong is the association between abdominal obesity and the incidence of type 2 diabetes?
Freemantle, N., Holmes, J., Hockey, A., & Kumar, S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01805.x · Cited by 236
The obesity pipeline: current strategies in the development of anti-obesity drugs
Cooke, D., & Bloom, S. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2136 · Cited by 215
Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E. J., & Wahli, W. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0036 · Cited by 214
Estrogen receptors: new players in diabetes mellitus
Barros, R. P. A., Machado, U. F., & Gustafsson, J.-Α. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.004 · Cited by 185
Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders
Ariazi, E. A., & Jordan, V. C. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026610606030203 · Cited by 169
Nishigori, H., Tomura, H., Tonooka, N., Kanamori, M., Yamada, S., Sho, K., Inoue, I., Kikuchi, N., Onigata, K., Kojima, I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.575 · Cited by 165
FXR: a promising target for the metabolic syndrome?
Cariou, B., & Staels, B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.002 · Cited by 159
Posttranslational Modifications of PPAR‐γ: Fine‐tuning the Metabolic Master Regulator
van Beekum, O., Fleskens, V., & Kalkhoven, E. (2009) · Obesity · doi:10.1038/oby.2008.473 · Cited by 153
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
Kersten, S. (2007) · PPAR Research · doi:10.1155/2008/132960 · Cited by 149
Estrogen receptor ß is involved in the anorectic action of estrogen
Liang, Y.-Q., Akishita, M., Kim, S., Ako, J., Hashimoto, M., Iijima, K., Ohike, Y., Watanabe, T., Sudoh, N., Toba, K., et al. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802054 · Cited by 147
Effects of ovariectomy on PPARα, SREBP-1c, and SCD-1 gene expression in the rat liver
Paquette, A., Wang, D., Jankowski, M., Gutkowska, J., & Lavoie, J.-M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31817b8159 · Cited by 137
Morani, A., Warner, M. N., & Gustafsson, J.-Α. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01976.x · Cited by 136
End of the line for cannabinoid receptor 1 as an anti-obesity target?
Jones, D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2775 · Cited by 135
Insulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 130
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
Reisin, E., & Jack, A. (2009) · The Medical clinics of North America · doi:10.1016/j.mcna.2009.02.010 · Cited by 114
Estrogen Regulation of Adipose Tissue Functions: Involvement of Estrogen Receptor Isoforms
Pallottini, V., Bulzomi, P., Galluzzo, P., Martini, C., & Marino, M. (2008) · Infectious Disorders - Drug Targets · doi:10.2174/187152608784139631 · Cited by 112
Obesity: Pathophysiology and Clinical Management
Gurevich-Panigrahi, T., Panigrahi, S., Wiecheć, E., & Łoś, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787315568 · Cited by 111
Expert Panel on Weight Loss Surgery: Executive Report Update
Blackburn, G. L., Hutter, M. M., Harvey, A. M., Apovian, C. M., Boulton, H. R. W., Cummings, S., Fallon, J. A., Greenberg, I., Jiser, M. E., Jones, D. B., et al. (2009) · Obesity · doi:10.1038/oby.2008.578 · Cited by 110
Narayanan, R., Adigun, A. A., Edwards, D. P., & Weigel, N. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.264-277.2005 · Cited by 110
Self-citationMammalian mitochondrial uncoupling proteins
Ježek, P., & Garlid, K. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00076-4 · Cited by 98
Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity
Leite, C. E., Mocelin, C. A., Petersen, G. O., Leal, M. B., & Thiesen, F. V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70025-8 · Cited by 89
Fan, X., Warner, M. N., & Gustafsson, J.-Α. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609663103 · Cited by 84
Morrison, C. D., Huypens, P., Stewart, L. K., & Gettys, T. W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.005 · Cited by 83
Estrogen Receptor α Regulates Expression of the Orphan Receptor Small Heterodimer Partner
Lai, K., Harnish, D. C., & Evans, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303913200 · Cited by 81
Pharmacologic Therapies for Obesity
Kaplan, L. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.01.001 · Cited by 73
Shin, E. S., Lee, H. H., Cho, S. Y., Park, H. W., Lee, S. J., & Lee, T. R. (2007) · Journal of Nutrition · doi:10.1093/jn/137.5.1127 · Cited by 71
Nakano, R., Kurosaki, E., Yoshida, S., Yokono, M., Shimaya, A., Maruyama, T., & Shibasaki, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.023 · Cited by 69
Pravettoni, A., Mornati, O., Martini, P. G. V., Marino, M., Colciago, A., Celotti, F., Motta, M., & Negri‐Cesi, P. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.08.008 · Cited by 69
Fabricatore, A. N., & Wadden, T. A. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095249 · Cited by 67
Hsieh, R. W., Rajan, S. S., Sharma, S. K., Guo, Y., DeSombre, E. R., Mrksich, M., & Greene, G. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513684200 · Cited by 63
PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Billin, A. N. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1465 · Cited by 58
Lipid transfer proteins: Past, present and perspectives
Quintão, E. C. R., & Cazita, P. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.002 · Cited by 50
Uncoupling Protein-2 Decreases the Lipogenic Actions of Ghrelin
Andrews, Z. B., Erion, D. M., Beiler, R. J., Choi, C. S., Shulman, G. I., & Horváth, T. L. (2010) · Endocrinology · doi:10.1210/en.2009-0850 · Cited by 48
Nakamura, T., Katsu, Y., Watanabe, H., & Iguchi, T. (2008) · Toxicology · doi:10.1016/j.tox.2008.09.006 · Cited by 46
Follettie, M. T., Pinard, M., Keith, J. C., Wang, L., Chelsky, D., Hayward, C., Kearney, P., Thibault, P., Paramithiotis, E., Dorner, A. J., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0600 · Cited by 45
Inflammatory Components of Adipose Tissue as Target for Treatment of Metabolic Syndrome
Yu, R., Kim, C.-S., & Kang, J. (2009) · Forum of nutrition/Bibliotheca Nutritio et dieta · doi:10.1159/000212742 · Cited by 29
Troglitazone is an estrogen-related receptor α and γ inverse agonist
Wang, Y., Fang, F., & Wong, C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.013 · Cited by 26
GPCR Drug Discovery: Novel Ligands for CNS Receptors
Lim, W. K. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907780832689 · Cited by 20
INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.
Kintscher, U., & Goebel, M. (2009) · PubMed · Cited by 17
Stevenson, J., & Brown, A. J. (2009) · Biochemical Journal · doi:10.1042/bj20090445 · Cited by 15
Effects of age on growth and ERbeta mRNA expression of canine prostatic cells.
Jiang, J., Chang, H.-L., Sugimoto, Y., & Lin, Y. C. (2005) · PubMed · Cited by 14
Women and the metabolic syndrome: an overview of its peculiarities.
Allende-Vigo, M. Z. (2008) · PubMed · Cited by 9
Molecular determinants of ERα and ERβ involved in selectivity of 16α-iodo-17β estradiol
Bhat, R. A., Stauffer, B., Unwalla, R. J., Xu, Z., Harris, H. A., & Komm, B. S. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.10.009 · Cited by 8
Novel obesity therapies set to attract spotlight in Q3 2009
Chang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2938 · Cited by 1
Die Bedeutung des Gehirns für die Regulation von Energie- und Glukosestoffwechsel
Rother, E., Jordan, S., & Brüning, J. C. (2009) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1222567 · Cited by 1
Research works printed but not linked: 3
- Allende-Vigo, 2008, P. R. Health Sci. J., 27, 190
- Kintscher, 2009, Curr. Opin. Investig. Drugs, 10, 381
- Jiang, 2005, Anticancer Res., 25, 4081
Cited by
Sorted by citations
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Paterni, I., Granchi, C., Katzenellenbogen, J. A., & Minutolo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.012 · Cited by 736
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Estrogen Receptors and the Metabolic Network
Barros, R. P. A., & Gustafsson, J.-Å. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.005 · Cited by 458
Stubbins, R., Holcomb, V. B., Hong, J., & Núñez, N. P. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0266-4 · Cited by 345
Metadata
- Authors
- Yepuru, M., Eswaraka, J., Kearbey, J. D., Barrett, C. M., Raghow, S., Veverka, K. A., Miller, D. D., Dalton, J. T., & Narayanan, R.
- Affiliations
- GTx (United States) (US)
- Corresponding author
- Dalton, James T.
- Narayanan, Ramesh
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 285
- Issue
- 41
- Pages
- 31292-31303
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2951204
- OpenAlex
- W2081999578
- Cited by
- 125
- References
- 73
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 3 · 2023: 8 · 2022: 12 · 2021: 6 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 15 · 2016: 8 · 2015: 11 · 2014: 7 · 2013: 12 · 2012: 5
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- estrogen receptor beta, obesity, high-fat diet, ovariectomy, adipose tissue, energy expenditure, body composition, metabolic disorders, ligand-binding domain, leptin, serum cholesterol
- MeSH terms
- Animals, Blood Glucose, Cholesterol, Dietary Fats, Disease Models, Animal, Female, Isoquinolines, Ligands, Male, Obesity, Organ Size, Ovariectomy, Transcription Factors, Rats, Sprague-Dawley, Leptin, PPAR gamma, Estrogen Receptor beta, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
